BackGlucoTrack Overview

GlucoTrack Total Assets

GlucoTrack's total assets is $4.4M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$4.36M
↓ 54.68% YoYΔ $-5.26M vs prior year quarter

Peer average

Loading

GlucoTrack Total Assets History

Loading

GlucoTrack vs. peers: Total Assets Comparison

Loading

GlucoTrack Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GlucoTrack (GCTK) FAQ

GlucoTrack (GCTK) currently reports a total assets of $4.4M as of March 2026. That compares with $9.6M in the prior-year period — down 54.7% year over year. Use the charts on this page to explore GlucoTrack's total assets history and peer comparisons.

GlucoTrack's total assets decreased from $9.6M to $4.4M — a 54.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GlucoTrack reported $4.4M in total assets as of March 2026. That compares with $9.6M in the prior-year period — down 54.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $4.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GlucoTrack, and consider following GCTK for alerts when major investors trade the stock.

GlucoTrack is classified in the Healthcare sector. On total assets, it currently shows $4.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GCTK with unrelated industries.